Madrigal Pharmaceuticals, Inc.
MDGL· Nasdaq
Released Nov 3, 2011, before the open
10-Q filed Nov 3, 2011, 34 days after period end · 0001104659-11-060264
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| EPS Diluted | -$0.26 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Madrigal Pharmaceuticals, Inc. · CIK 1157601 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 3, 2011 · 34 d after period end